KDAGF (KDA Group) Moat Score: 1/10 (As of Jul. 06, 2026)


What is KDA Group Moat Score?

KDA Group KDAGF Moat Score is 1 as of Jul. 06, 2026. The stock has 3 warning signs investors should review. Among 676 Healthcare Providers & Services companies, KDA Group ranks better than 74.85% on this metric.

KDA Group has the Moat Score of 1, which implies that the company might have No Moat - Very weak/transient advantages.

KDA Group has No Moat: KDA Group Inc lacks market leadership, proprietary technology, and significant customer loyalty. It operates in a competitive industry with no discernible cost advantages or regulatory barriers, resulting in a very weak competitive position.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes KDA Group might have No Moat - Very weak/transient advantages.

KDA Group  (OTCPK:KDAGF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

KDA Group Moat Score Related Terms

KDAGF vs VEEV, BTSG, TEM: Moat Score Comparison

For the Health Information Services subindustry, KDA Group's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

KDA Group Moat Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, KDA Group's Moat Score distribution charts can be found below:

* The bar in red indicates where KDA Group's Moat Score falls into.


Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 1 mean?
KDA Group (KDAGF) has a Moat Score of 1 as of Jul. 06, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, KDA Group ranks #170 out of 676 companies in the Healthcare Providers & Services industry, placing it in the top 25.1%.
Is KDA Group's Moat Score too high?
KDA Group's current Moat Score is 1. Based on the distribution chart, KDA Group ranks #170 out of 676 companies in the Healthcare Providers & Services industry, which is above the industry midpoint.
How does KDA Group's Moat Score compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, KDA Group ranks #170 out of 676 companies for Moat Score. This puts KDA Group in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Healthcare Providers & Services company?
A good Moat Score depends on the Healthcare Providers & Services industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. KDA Group's current Moat Score is 1. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KDA Group stock overvalued right now?
KDA Group (KDAGF) has a current Moat Score of 1. The current Moat Score is 1. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For KDA Group (KDAGF), the current Moat Score is 1 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

KDA Group Business Description

Other Exchanges O1M:GermanyKDA:Canada
Address 1351 Notre-Dame East, Suite 300, Thetford Mines, QC, CAN, G6G 0G5
KDA Group Inc provides technological and operational efficiency solutions for general and specialized health sectors through its technology platform, which includes electronic prescription platforms for Canada and the United States and Adherize and Medherize functionalities for pharmaceutical adherence and oncology-focused therapeutic monitoring. The company operates through two segments: Pharmaceutical Technology and Corporate.